国际妇产科学杂志 ›› 2025, Vol. 52 ›› Issue (3): 312-314.doi: 10.12280/gjfckx.20250055

• 产科生理及产科疾病: 病例报告 • 上一篇    下一篇

一个CTNNB1基因变异家系的遗传学分析

黄芬芳, 张兰兰, 黄艳华, 梁佩   

  1. 535000 广西壮族自治区钦州市妇幼保健院医学遗传与产前诊断科
  • 收稿日期:2025-01-15 出版日期:2025-06-15 发布日期:2025-06-19

Genetic Analysis of A Family with CTNNB1 Gene Variation

HUANG Fen-fang, ZHANG Lan-lan, HUANG Yan-hua, LIANG Pei   

  1. Department of Medical Genetics and Prenatal Diagnosis, Qinzhou Maternal and Child Health Hospital, Qinzhou 535000, Guangxi Zhuang Autonomous Region, China
  • Received:2025-01-15 Published:2025-06-15 Online:2025-06-19

摘要:

对一个神经发育障碍伴痉挛性双侧瘫痪和视觉缺陷罕见病家系的致病基因变异位点进行检测并进行遗传学分析。先证者因严重的智力障碍、语言障碍、痉挛性双侧瘫痪、斜视、特殊面容就诊于钦州市妇幼保健院,收集先证者及家系成员的临床资料,先证者母亲具有与先证者相同的表型且已妊娠23周,余家系成员无异常表型。采集该家系成员外周血样及先证者母亲的羊水,应用全外显子组测序技术进行基因检测。先证者及其母亲基因检测结果提示CTNNB1基因外显子11存在c.1759C>T(p.R587*)的杂合突变,先证者的该变异遗传自其智力障碍的母亲,该变异使CTNNB1基因第1759位核苷酸的胞嘧啶(C)被胸腺嘧啶(T)取代,导致第587位氨基酸变为终止密码子。SWISS-MODEL软件分析提示该变异位点导致蛋白质结构发生改变,产生截短蛋白。根据美国医学遗传学与基因组学学会《遗传变异分类标准与指南》,c.1759C>T(p.R587*)评级为致病性变异(PVS1+PS2+PM2-Supporting)。先证者外祖父母及先证者父亲未检测到该变异;羊水检测未携带该变异,胎儿出生至今未发现异常。先证者及其母亲CTNNB1基因的杂合变异考虑为导致该母子神经发育障碍伴痉挛性双侧瘫痪和视觉缺陷的致病原因,基因检测技术可以辅助临床医师进行疾病的诊断。

关键词: 智力障碍, 视觉障碍, 脑性瘫痪, 病例报告, CTNNB1基因

Abstract:

This study aimed to detect the pathogenic gene variation sites in a rare disease family with neurodevelopmental disorder accompanied by spastic bilateral paralysis and visual deficiency and conduct genetic analysis. The proband presented at Qinzhou Maternal and Child Health Hospital due to severe intellectual disability, language disorder, spastic diplegia, strabismus and special facial features. Clinical data of the proband and family members were collected. The proband’s mother had the same phenotype as the proband and was 23 weeks pregnant, while other family members had no abnormal phenotypes. Peripheral blood samples of family members and amniotic fluid from the proband’s mother were collected, and whole-exome sequencing technology was applied for gene detection. The gene detection results of the proband and his mother indicated a heterozygous mutation c.1759C>T (p.R587*) in exon 11 of the CTNNB1 gene. The proband inherited this variation from his mother with intellectual disability. This variation replaced the cytosine (C) at nucleotide 1759 of the CTNNB1 gene with thymine (T), resulting in the 587th amino acid being changed to a stop codon. Analysis by the SWISS-MODEL software suggested that the mutation site led to a change in the protein structure, resulting in a truncated protein. According to the Standards and Guidelines for the Interpretation of Sequence Variants of the American College of Medical Genetics and Genomics, c.1759C>T (p.R587*) was rated as a pathogenic variation (PVS1+PS2+PM2-Supporting). The mutation was not detected in the proband’s maternal grandparents and father. The amniotic fluid test showed that the fetus did not carry this mutation, and no abnormalities have been found since birth. The heterozygous variation of the CTNNB1 gene in the proband and his mother is considered to be the pathogenic cause of neurodevelopmental disorder accompanied by spastic bilateral paralysis and visual deficiency. Gene detection technology can assist clinicians in disease diagnosis.

Key words: Intellectual disability, Vision disorders, Cerebral palsy, Case reports, CTNNB1 gene